The Role of Foxp3-Expressing Regulatory T Cells and T Helpers in Immunopathogenesis of Multidrug Resistant Pulmonary Tuberculosis by Churina, E. G. et al.
Hindawi Publishing Corporation
Tuberculosis Research and Treatment
Volume 2012, Article ID 931291, 9 pages
doi:10.1155/2012/931291
Research Article
T heR oleo fFoxp3-ExpressingRegulatory TCellsand
T HelpersinImmunopathogenesisof Multidrug Resistant
Pulmonary Tuberculosis
E.G.Churina,O.I.Urazova,andV.V.Novitskiy
SBEI-HPE “Siberian State Medical University of the Ministry of Health Care and Social Development of the Russian Federation”,
Tomsk, Russia
Correspondence should be addressed to E. G. Churina, lena1236@yandex.ru
Received 3 December 2011; Revised 19 February 2012; Accepted 27 February 2012
Academic Editor: Giovanni Battista Migliori
Copyright © 2012 E. G. Churina et al. This is an open access article distributed under the Creative Commons Attribution License,
which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Subpopulation structure of regulatory T cells and T helpers of peripheral blood in patients with newly diagnosed pulmonary
tuberculosis depending on the clinical form of disease and sensitivity of Mycobacterium tuberculosis to antituberculosis drugs
has been analyzed in this work. It has been shown that the leading part in immune suppression at inﬁltrative, dissemination,
and ﬁbrosis-cavity pulmonary tuberculosis is played by natural regulatory CD4+CD25+Foxp3+-T lymphocytes. Thus we
estimate increase of their number in blood by drug-resistance and drug-susceptible patients. It has been demonstrated that
in patients with ﬁbrocavernous and inﬁltrative form of the disease and drug-resistant pulmonary tuberculosis the number of
CD4+CD25−Foxp3+-regulatory T cells was increasing. In patients with inﬁltrative pulmonary tuberculosis, including multidrug-
resistant M. tuberculosis, an increased number of CD3+CD4+CD25− T helpers is determined by the pathogenic features of the
development of the tuberculosis infection and is connected with the activation of Th1-dependent immune response. Reduction
in the number of T-helpers in the blood of patients with dissemination and ﬁbrosis-cavity pulmonary tuberculosis mediates
ineﬃcient implementation of cell-mediated protective immunity.
1.Introduction
Drug-resistant pulmonary tuberculosis (DR-TB) is a case
of tuberculosis caused by M. tuberculosis strains (MBTs)
which are drug resistant to the eﬀect of antituberculosis
drugs (ATDs). It is supposed that drug-resistance (DR) is,
above all, connected with accumulation of mutations in
M. tuberculosis genes [1]. Multidrug-resistant tuberculosis
(MDR-TB) is a special form of drug-resistant TB. It develops
incaseofresistanceofM.tuberculosisatleasttoisoniazidand
rifampicin—the two most powerful ATDs [2]. The problem
of multidrug resistance of a tuberculosis causative agent
to ATD in newly detected patients has lately gained global
importance [3, 4]. According to the data of World Health
Organization (2010), based on the information received
from 114 countries around the world, primary MDR of
MBT comprises about 4% from all newly detected TB
cases, whereas on the territory of the CIS countries (Russia,
Belarus,Ukraine,Kazakhstan,Armenia,andAzerbaijan)this
indicator is 3–6 times higher [2].
Increase in morbidity of cases with primary DR-TB
in patients who earlier did not receive ATD is especially
alarming [5, 6]. Primary DR-TB develops as a result of
primary infection by drug-resistant M. tuberculosis strains.
In some regions of Russia secondary (acquired) DR-TB
to ATD among earlier treated patients reaches 88% [5,
7]. Besides, an unfavorable tendency towards the increase
in speciﬁc gravity of polyresistance and the decrease in
speciﬁc gravity of monoresistance to ATD is marked; that
is, at present MDR-TB is encountered more frequently
among TB patients than DR-TB [5, 6]. A serious problem
is a rise in the number of cases of primary DR to the
most active chemical drugs—isoniazid and rifampicin—
which, in combination with resistance to other ﬁrst-line
ATD or without it, is classiﬁed as MDR-TB, whereas in
combination with resistance to second-line drugs, including2 Tuberculosis Research and Treatment
ﬂuoroquinolones and one of the injectable drugs (such as
kanamycin or capreomycin), it is classiﬁed as XDR-TB [3, 5].
Clinical treatment of patients with MDR-TB is 3 times
less than of those with TB whose causative agent is sensitive
to ATD, in other words, eﬀectiveness of treatment of such
patients, which is determined by the cease in bacterioexcre-
tion, is 3 times lower in MDR-TB than in drug-resistant
variants of the disease. Besides, the frequency of termination
of selection of ATD-sensitive MBT in patients reaches
92,5%, whereas in cases of TB caused by resistant strains
of the causative agent only 58,1% [5, 8]. Therefore, ATD-
multiresistant MBT becomes the major component of TB
morbidity and mortality, which poses a serious threat to the
whole mankind [2–5].
It is obvious that the above-stated problem requires
many-sided and integrated approaches to its solution, the
main of which is studying of immunopathogenic pro-
cesses accompanying the course of pulmonary tuberculosis.
Nowadays it is commonly believed that the development
and the progressive course of the tubercular infection are
impossible without functional defects in the protective cell
immunity system [9]. Enhanced proliferation and excessive
activity of regulatory T cells, which tend to weaken the
anti-infectious organism immunity, are at present viewed
as one of the mechanisms of Th-1-dependent immune
response suppression, aimed at elimination of pathogens of
various nature [10–12]. From all the identiﬁed regulatory
T cells (Treg) subpopulations, Treg, expressing intracellular
transcription factor Foxp3, which is the most precise marker
of regulatory T-lymphocyte identiﬁcation, has today the
most functional activity in the aspect of implementation
of immunosuppressive mechanisms. It is worth mentioning
that Foxp3-positive regulatory T cells can be both natural
(formed in the course of antigen-dependent diﬀerentiation
in the thymus) and induced in the periphery in the process
of adaptive immune system [13, 14]. One of the major
indicators of Treg functional activity is their suppression of
proliferation of T-helper eﬀector clones, which mediates T-
cell anergy formation.
The Objective of the Work. To deﬁne the role of Foxp3-ex-
pressing regulatory T cells and T helpers in immunopatho-
genesis of multidrug-resistant pulmonary tuberculosis.
2.MaterialsandMethods
The diagnosis of pulmonary tuberculosis was put on the
basis of the clinical picture of the disease as well as X-
ray lungs examination and data of microscopic and bacte-
riological sputum tests. The causative agent of tuberculosis
was detected by means of direct light microscopy of the
sputum smear, with the use of Ziehl-Neelsen stain, by
the method of ﬂuorescence microscopy with the use of
ﬂuorochromes (auramine). For species identiﬁcation of M.
tuberculosis and deﬁnition of sensitivity to anti-TB chemod-
rugs (a method of absolute concentration), we conducted
sputum culture on dense Lowenstein-Jensen and Finn-2
media.
2.1. Microbiological Research Methods. To determine drug
resistance of M. tuberculosis to basic ATD (rifampicin (RIF),
isoniazid (INH), streptomycin, and ethambutol), we used
the traditional bacteriological method of absolute concen-
trations. To carry out microbiological tests, we collected
sputum in sterile 50mL plastic test tubes with hermetically
sealed screw caps. After sputum decontamination and MTB
concentrating, the washed MTB sediment was used for
culture on dense Lowenstein-Jensen medium with further
detection of MTB sensitivity to RIF, INH, streptomycin, and
ethambutol using the bacteriological absolute concentration
method.
Mononuclear cells of peripheral blood, which was taken
in the quantity of 10mL from the cubital vein on an empty
stomach in the morning, before the course of speciﬁc anti-
tubercular therapy, served as the material of the research.
Mononuclear cells of peripheral blood were isolated by
gradient centrifugation [15].
2.2. Isolation of Mononuclear Leucocytes from Whole Blood.
Heparinized venous blood (25units/mL) was kept at
the temperature of 37◦C for 30min to separate plasma
from erythrocytes. The obtained plasma was layered on
Ficoll-urograﬁn (ρ = 1077g/cm3) density gradient (“MP
Biomedical, LLC”, USA) in a 1:2 ratio and centrifuged
at 1500rev/min for 20min. The resulting interphase ring
consisting of a mixture of mononuclear cells was collected
with a pipette and then thrice washed with RPMI-1640
medium (“Vektor,” Russia), which was supplemented with
100mkg/mL of gentamicin and 5% inactivated fetal calf
serum (“BioloT LLC”, Russia), being consistently resus-
pended and centrifuged once every 10min at 1500rev/min.
When using the gradient with the above-stated density, 90–
95% of all the isolated mononuclear cells were lymphocytes.
2.3. Determination of the Quantity of CD4+CD25+Foxp3+,
CD4+CD25+FoxP3−, and CD4+CD25−FoxP3 Regulatory T
Cells in Peripheral Blood. To deﬁne CD4, CD25 superﬁcial
receptorsandFoxp3 intracellularmarkerofimmunosuppres-
sion activity in peripheral blood lymphocytes, we used the
method of laser three-color cytometry with the use of ﬂuo-
rescently labeled multichannel antibodies (MCAB). Staining
ofsuperﬁcial(CD4,CD25)andintracellular(Foxp3)mark ers
was conducted according to the protocol of the manufactur-
ing company (“Becton Dickinson (BD),” USA).
Course of Work. After isolation, the mononuclear leucocytes
were twice washed with phosphate-saline buﬀer (pH = 7,4)
the amount of cells in the suspension was standardized to
10 × 106 cells/mL. To stain superﬁcial markers (CD4, CD25)
of the peripheral blood leucocytes, 20mcl of the correspond-
ing ﬂuorescently labeled MCAB was added to the suspen-
sion of mononuclear leucocytes: to CD4—FITC-labeled, to
CD25—PE-Cy5-labeled (“Becton Dickinson (BD)”, USA)
and then incubated at room temperature for 20min, while
providing protection from light. To stain the intracellular
marker Foxp3 the process of cell permeabilization was
conducted. For this we alternately added working solutionsTuberculosis Research and Treatment 3
of standard buﬀers to every test tube: Human FoxP3 Buﬀer
Aa n dH u m a nFoxP3 Buﬀer C from the set BD Pharmingen
Human FoxP3 Buﬀer Set Cat. No. 560098. The buﬀers
were diluted according to the instruction (cat. No. 560098).
Leucocytes have been incubated for 30min in a dark place
at room temperature. Then the cells were twice washed
with 2mL of phosphate-saline buﬀer (PH = 7,4). PE-labeled
antibodies in the amount of 20mcl were added in the
resuspendedsedimenttotheintracellularmarkerFoxp3.This
solution has been incubated for 30min in a dark place at
room temperature. Then the cells were twice washed with
2mL of phosphate saline buﬀer (PH = 7,4).
Measurements were carried out on a cytoﬂuorimeter
FACSCalibur (Becton Dickinson, USA), which has a laser
with 488nm wavelength as well as standard ﬁlters. The
analysis of the obtained data was performed by means of a
software application BD Cell CellQuest for Mac OS X.
2.4. Determination of the Amount of CD3+CD4+CD25−
T Helpers in Peripheral Blood. To determine the level of
expression of superﬁcial receptors CD3, CD4, and CD25 in
peripheral blood lymphocytes, we used the method of laser
three-colorﬂowcytometrywithﬂuorescentlylabeledMCAB.
Staining of the markers CD3, CD4, and CD25 was
conducted according to the protocol of the manufacturing
company (“Becton Dickinson (BD),” USA).
T h eC o u rseo fW o rk . After isolation, mononuclear leucocytes
were twice washed with phosphate saline buﬀer (pH = 7,4),
every time having been resuspended and centrifuged for
10min at 1500rev/min. Then the supernatant was drained
oﬀ, the remaining sediment was resuspended in phosphate-
saline buﬀer, and the amount of cells was standardized in
the suspension to 10 × 106 cells/mL. To stain lymphocytes,
we added 50mcl of the mononuclear leucocyte suspension
and 20mcl of conjugated MCAB-CD3 (PerCP-Cy5,5)/CD4
(FITC)/CD25 (PE) (“Becton Dickinson (BD)”, USA, cat. No.
333170) to every cytometric test tube, mixed on vortex and
incubated for 15min in a dark place at room temperature.
MeasurementswerecarriedoutonacytometerFACSCal-
ibur(BectonDickinson,USA),whichhasanargonlaserwith
488nm wavelength as well as standard ﬁlters. The analysis
of the obtained data was conducted by means of a software
application BD CellQuest for Mac OS X.
2.5. Statistical Processing of the Research Results. Analysis of
the primary data was conducted using the methods of statis-
tical description and veriﬁcation of statistical hypotheses. All
quantitative indicators were tested for normal distribution
using Shapiro-Wilks test. For normally distributed samples,
wecalculatedaveragesamplecharacteristics:arithmeticaver-
age (X), mean square deviation (σ), and error of mean (m).
Forthesampleswhichdistributiondiﬀeredfromnormalone
we calculated median (M) as well as the ﬁrst and the third
quartiles (Q1,Q3).
When the feature in the researched samples corre-
sponded with the normal law of distribution, veriﬁcation
of hypotheses about equality of average sample values was
conducted using unifactor variance analysis. To evaluate cer-
tainty of diﬀerences of the sample numerical characteristics
which are not subject to normal distribution, we used the
Kruskal-Wallis test. For pairwise comparison of indicators
in the researched groups, we used the Mann-Whitney test
for independent groups. The diﬀerence in indicators in the
compared groups was considered statistically signiﬁcant at
the signiﬁcant level P ≤ 0,05. Calculations were performed
using the program Statistica 6.0.
3. Results and Discussion
115 patients with advanced destructive forms of newly
detected pulmonary tuberculosis (85 men and 30 women
at the age of 18–55, average age 44 ± 12 years) have been
examined. All patients were divided into 3 groups according
to the clinical form of the disease: a group with inﬁltrative
pulmonary tuberculosis (ITB) contained 65 people, with
disseminated pulmonary tuberculosis (DTB) 31 people,
with ﬁbrous-cavernous pulmonary tuberculosis (FCTB) 19
people. When dividing the patients into groups, we took into
account drug sensitivity of the causative agent to the basic
ATD: the group of patients having MBT sensitive to basic
ATD contained 68 people and the second group included
47 patients with MBT resistant to the ﬁrst-line ATD (such
as isoniazid, rifampicin, streptomycin, and ethambutol).
The control group included 26 healthy donors with
similar sex and age characteristics (16 men and 10 women
at the age of 18–55, average age 44 ± 12 years).
The carried-out research allowed us to conclude that the
amount of T helpers in blood of TB patients is changing
multidirectionally depending on the clinical form of the
disease and sensitivity of M. tuberculosis to ATD. It has been
revealed that the increase in the number of lymphocytes
with immunophenotype CD3+CD4+CD25− (T-helpers) is
registered in the group of ITB patients (in comparison with
the group of healthy donors), whereas in the groups of
disseminated and ﬁbrous-cavernous TB patients the number
of CD3+CD4+CD25− cells is decreasing (Table 1). Under TB
withMDR-TB,theamountofThelpersisbiggerinthegroup
of ITB and DTB than in that of DS TB patients, whereas
under FCTB the presence or absence of drug resistance of M.
tuberculosisdoesnotaﬀecttheamountofThelpers(Table 1).
It should be noticed that the above-stated sub-
population of T lymphocytes is heterogeneous and forms
the general idea of the amount of T helpers in blood of TB
patients. Initially it was thought that T helpers are diﬀeren-
tiated into two stable subpopulations: T helpers (Th) Th1
and Th2, the characteristic feature of which is production
of immunoregulatory cytokines, multidirectional in their
spectrum of action [16]. However, the research carried out
in recent years allowed us to determine that among CD-
4-positive T lymphocytes there are other cells which have
“helper” functions. In particular, it was demonstrated that
among CD4+ T lymphocytes there are Th17, Treg, and
adaptiveregulatoryTcells:Th3,Tr1,andFoxp3+ Treg, which
are formed in the course of immune response, as well as
Th-activated cells and recently identiﬁed follicular T-helpers4 Tuberculosis Research and Treatment
Table 1: Relative amount of T helpers (CD3+CD4+CD25−) in peripheral blood of patients suﬀering from pulmonary tuberculosis,
depending on the form of the disease and sensitivity of the causative agent to antitubercular drugs (%), Me (Q 1–Q 3).
Type of a researched
patients
Relative amount of T
helpers in the group
Relative amount of T helpers in the group
depending on sensitivity of the causative
agent to antitubercular drugs
DS TB MDR TB
Healthy donors 35,38 (32,74–38,74)
Patients with ITB
45,47 38,20 54,41
(43,07–47,82) (33,04–47,88) (54,38–54,89)
p1 = 0,038 p1 = 0,042
p4 = 0,036
Patients with DTB
31,61 23,90 39,38
(29,33–34,41) (16,84–26,66) (24,57–48,75)
p1 = 0,042 p1 = 0,043 p1 = 0,049
p2 = 0,042 p2 = 0,041 p2 = 0,041
p4 = 0,048
Patients with FCTB
25,46 24,4 26,0
(21,38–32,86) (22,38–25,35) (21,20–28,70)
p1 = 0,029 p1 = 0,037 p1 = 0,041
p2 = 0,048 p2 = 0,045 p2 = 0,028
p3 = 0,035 p3 = 0,039
Note: p1: the level of statistical signiﬁcance of diﬀerences in comparison with the group of healthy donors; p2: in ITB patients; p3: in DTB patients; p4:i nD S
TB patients.
(TFH), whose function presumably lies in protection from
extracellularpathogens[13,17].Apeculiarfeatureofspeciﬁc
immuneresponseunderITBisrelativelyadequaterealization
of Th1-dependent inﬂammatory response, the eﬀector cells
of which are CD4+ T lymphocytes. In connection with this,
the increase in the number of CD4+ T-cells under ITB is
viewed as a logical fact. At the same time the above-shown
decrease in the total amount of T-helpers in blood of DTB
and FCTB patients is the evidence of inhibition of clonal
proliferation of CD4+ T cells (Table 1).
As for the patients with inﬁltrative and disseminated
MDR TB, where the biggest amount of T helpers was
detected in comparison with DS TB and healthy donors,
is it likely that drug-resistant strains of MBT do not
have a pathological eﬀect on the process of T lymphocyte
diﬀerentiation and proliferation under acute and subacute
MDR TB, which include ITB and DTB? Nevertheless, to
answer this question, further more profound studying of the
subpopulation composition of T-helpers in TB patients is
necessary.
As is known, natural Treg cells with the phe-
notype CD4+CD25+Foxp3+ and adaptive regulatory
CD4+CD25−Foxp3+ T-lymphocytes are key suppressor
cells of the immune response [13, 14]. The analysis of the
amount of Foxp3-expressing regulatory T cells has shown
that in all TB patients, irrespective of the clinical form of the
disease, the increase in the number of CD4+CD25+Foxp3+
Treg is deﬁned in comparison with the group of healthy
donors, whereas the number of CD25-negative regulatory
T cells, containing the Foxp3 molecule, is rising only in
FCTB patients (Table 2). In Figures 1, 2, 3,a n d4 Treg cells
with the phenotype CD4+CD25+Foxp3+ are localized in the
right upper quadrants and CD4+CD25−Foxp3+ cells in the
left-upper quadrants.
This fact allows us to suggest that in the case of chronic
destructive process in Treg-mediated speciﬁc immunosup-
pression, regulatory T cells, both natural as well as formed,
are involved in the course of the adaptive immune response.
Tuberculosis, with the exception of acutely progressive
forms, is considered to be “slow” infection, whose feature
is long-ﬂowing, but unfortunately, poor immune response
against the background of abundance of a constantly per-
sistent antigen. The previous studies we conducted have
shown that dysregulation of cytokine production is met in
patients with TB, and, in particular, the hypersecretion of
immunoregulatorycytokineswithsuppressoractivity(IFNγ,
IL-4, IL-10, TGF-β) against the background of reduction
of the secretion of IL-2 has been found out [18]. In
this regard, as demonstrated in this study, the reduction
in the number of T lymphocytes with the phenotype
CD4+CD25+Foxp3− in all clinical forms of TB (Table 2)i s
more likely connected with imbalance of cytokine produc-
tion with a predominance of secretion of immunosuppres-
sive cytokines and, consequently, the inhibition of not only
proliferation, but also diﬀerentiation of Th0 into activated
antigenspeciﬁc Th1-lymphocytes. In Figures 1, 2, 3,a n d4
the CD4+CD25+Foxp3− cells are localized in the right-lower
quadrants. Interestingly, the fate of selection occurring in
the thymus of Foxr3-negative CD4+CD25+ regulatory T cells
by activation of endogenous (mitochondrial) apoptosis afterTuberculosis Research and Treatment 5
Table 2: Subpopulation composition of regulatory T cells of peripheral blood in patients suﬀering from pulmonary tuberculosis, depending
on a clinical form of the disease (%), Me (Q 1–Q 3).
Groups of the researched
patients
Relative content of regulatory T-cell subpopulations
CD4+CD25+Foxp3+ CD4+CD25−Foxp3+ CD4+CD25+Foxp3−
Healthy donors 2,63 5,12 25,45
(2,00–3,29) (4,76–9,75) (22,30–27,60)
ITB patients
4,48 6,95 17,52
(3,10–6,00) (5,50–11,20) (9,400–22,60)
p1 = 0,047 p1 = 0,036
DTB patients
5,35 6,30 13,50
(3,75–7,14) (5,50–8,00) (8,400–17,20)
p1 = 0,014 p1 = 0,005
p2 = 0,026
FCTB patients
4,80 8,50 19,50
(3,20–6,00) (4,20–11,50) (13,400–24,30)
p1 = 0,045 p1 = 0,049 p1 = 0,038
p2 = 0,047
p3 = 0,049
Note: p1: the level of statistical signiﬁcance of diﬀerences in comparison with the group of healthy donors; p2:i nI T Bp a t i e n t s ;p3:i nD T Bp a t i e n t s .
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Figure 1: Individual bar chart of distribution of regulato-
ry T cells in a population of CD4-positive blood lympho-
cytes, expressing CD25 and Foxp3, in a healthy person. Rel-
ative content of CD4+CD25+Foxp3+ cells (upper-right quad-
rant) 3,02%, CD4+CD25−Foxp3+ cells (upper-left quadrant)—6%,
CD4+CD25+Foxp3− cells (lower-right quadrant)—26%.
their migration into the circulating blood and secondary
lymphoid organs is further determined by diﬀerent mech-
anisms of immune regulation, many of which are still not
established [19, 20].
As our studies have shown, the number of CD4+
CD25+Foxp3+ Treg lymphocytes in the blood of pa-
tients with ITB and DTB, regardless of the drug sensitivity
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Figure 2: Individual bar chart of distribution of regulatory T cells
in a population of CD4-positive lymphocytes of blood, expressing
CD25 and Foxp3, in a patient with inﬁltrative pulmonary tuber-
culosis (patient N., 39 years old, diagnosed with inﬁltrative tuber-
culosis S1-2 of the right lung in a phase of decay and semination,
MTB (+)). The relative abundance of CD4+CD25+hiFoxp3+ cells
(upper-right quadrant) is 5%, CD4+CD25−Foxp3+ cells (upper-left
quadrant) is 7%, CD4+CD25+Foxp3− cells (lower-right quadrant)
is 13.5%.
of the causative agent to anti-tuberculosis drugs before
speciﬁc therapy, that is, in the acute phase of tuberculous
infection, has been rising with respect to the number of
CD4+CD25+Foxp3+ Treg lymphocytes in healthy donors,
as well as in general in the groups (Tables 2 and 3).6 Tuberculosis Research and Treatment
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Figure 3: Individual bar chart of distribution of regulatory T cells
in a population of CD4-positive lymphocytes of blood, expressing
CD25 and Foxp3, in a patient with disseminated pulmonary
tuberculosis (patient S., 28 years old, diagnosed with subacute
disseminated pulmonary tuberculosis in the phase of inﬁltration
and decay, MTB (+)). The relative content of CD4+CD25+hiFoxp3+
cells (upper-right quadrant) is 8%, CD4+CD25−Foxp3+ cells
(upper-left quadrant) is 11,5%, CD4+CD25+Foxp3− cells (lower-
right quadrant) is 23.3%.
A similar pattern was also observed in FCTB with MDR of
the causative agent (Table 3).
In our opinion, such changes primarily contribute to the
formation of suppression of Th1-response to prevent the
development of hyperergic immune responses and damage
of lung tissue. For example, in the studies of Raghvan and
Holgren [21]a n dL e ee ta l . ,[ 10] the deterrent role of
Treg in the development of intensive immune inﬂammation
and immune pathology accompanying various infectious
processes has been shown [21, 22].
However, in the long run, this, to some extent, compen-
satory reaction associated with increased proliferation and
diﬀerentiation of Treg, leads to negative consequences in the
form of weakening of the eﬀectiveness of protective immu-
nity, promoting generalization and chronicity of infection
[23].
ItisclearthatincreasingnumbersofCD4+CD25+Foxp3+
Treg in blood of patients with TB are an unfavorable factor.
The main way of realization of the eﬀect of Treg is through
the implementation of triple-contact interaction, in which,
together with Treg and target cells, the tolerogenic dendritic
cells(TDCs)areinvolved[13,24].TDCandTreghavemutu-
ally activating properties, presumably by contacting “cell-to-
cell.” Perhaps, Treg prevents the formation of the immune
synapse between TDC and eﬀector T cell. It is assumed that
the basis of this mechanism is competitive interaction of the
negativeactivatorCTLA-4(cytotoxicT-lymphocyteantigen-1)
with costimulatory molecules B7 (CD80/86) on the surface
oftargetcells,promotingtheformationofT-cellanergy[13].
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Figure 4: Individual bar chart of distribution of regulatory T cells
in a population of CD4-positive lymphocytes of blood, expressing
CD25 and Foxp3, in a patient with ﬁbrous-cavernous pulmonary
tuberculosis (patient S., 53 years old, diagnosed with ﬁbrous-
cavernous tuberculosis of the upper lobe of the left lung in a
phase of inﬁltration and semination, MTB (+)). The relative
content of CD4+CD25+hiFoxp3+ cells (upper-right quadrant) is
11%, CD4+CD25−Foxp3+ cells (upper-left quadrant) is 13,5%,
CD4+CD25+ Foxp3− cells (lower-right quadrant) is 25.3%.
Thus, an increasing number of Treg in almost all clinical
forms and variants of the TB course lets us suggest that they
carryoutmajorimmunosuppressivefunctionintuberculosis
infection.
It is known that Treg cells with the phenotype CD4+
CD25+Foxp3+ “are trained” in the thymus at the stage of
negative selection and leave the thymus as the population
of natural Treg, which has maximum suppressor activ-
ity. At the same time it is shown that a subpopulation
CD4+CD25+Foxp3+ Treg is replenished in the peripheral
section of immune system at the expense of their devel-
opment from CD4+CD25− T cells (the conversion of T-
helpers into the regulatory T-cells) as a result of intercellular
interactions with participation of costimulatory molecules
with action of TGF-β a n di nt h ep r e s e n c eo fT D C[ 13].
Conversion is a manifestation of the expression of the Foxp3
molecule within a cell, as well as molecules CD25 and
CTLA-4 on its surface [19]. In connection with the above-
mentioned information, it is logical to assume that rather
high number of adaptive regulatory T cells in the blood of
patients with TB is caused not only by activation of inter-
cellular interactions, but also by the enhanced production
of cytokine-inductor Treg-TGF-β in pulmonary tuberculosis
[18]. In addition, the source of CD4+CD25+Foxp3+ Tc e l l s
could also be CD4+CD25−Foxp3− T-helpers, which are
diﬀerentiated in the thymus and which form a reserve
pool for the formation of CD25+ Treg lymphocytes
[11, 24].Tuberculosis Research and Treatment 7
Table 3: Subpopulation composition of regulatory T cells of peripheral blood in patients suﬀering from pulmonary tuberculosis, depending
on a clinical form of the disease and sensitivity of the causative to antituberculosis drugs (%), Me (Q 1–Q 3).
Groups of patients
Relative content of regulatory T-cell subpopulations
CD4+CD25+Foxp3+ CD4+CD25−Foxp3+ CD4+CD25+Foxp3−
Healthy donors 2,63 5,12 25,45
(2,00–3,29) (4,76–9,75) (22,30–27,60)
ITB patients
DS TB
4,32 5,81 9,72
(4,12–8,25) (4,12–9,63) (7,14–21,69)
p1 = 0,007 p1 = 0,003
MDR TB
5,08 8,41 16,27
(3,12–7,42) (5,62–11,58) (9,13–25,92)
p1 = 0,039 p1 = 0,005 p1 = 0,048
p4 = 0,037 p4 = 0,017
DTB patients
DS TB
5,31 5,63 13,71
(2,84–9,48) (3,79–8,47) (9,64–17,08)
p1 = 0,015 p1 = 0,006
MDR TB
4,42 6,75 13,98
(3,17–7,53) (4,82–8,16) (7,52–17,80)
p1 = 0,038 p1 = 0,006
FCTB patients
DS TB
2,72 3,25 19,62
(2,09–3,66) (2,17–5,82) (11,31–31,75)
p3 = 0,013 p2 = 0,014 p3 = 0,018
MDR TB
6,82 12,27 17,68
(3,17–10,42) (8,45–13,09) (12,42–23,19)
p1 = 0,003 p1 = 0,017
p4 = 0,039 p4 = 0,015
Note: p1: the level of statistical signiﬁcance of diﬀerences in comparison with features of healthy donors; p2:i nI T Bp a t i e n t s ;p3: in DTB patients; p4:i nD S
TB patients.
Regulatory T cells with the phenotype CD4+CD25−
Foxp3+ in the absence of expression on the surface of CD25
markerareconsideredtobeinduced,thatis,generatedonthe
peripheryundertheinﬂuenceofTGF-β,astheexpressionsof
the Foxr3 marker largely contribute to TGF-β among all the
cytokines suppressors [9, 25]. We found the increase in the
number of CD4+CD25−Foxp3+ regulatory T cells in patients
with MDR TB compared to drug-sensitive variant of the
disease in ITB and FCTB patients (Table 3).
Perhaps this could be induced by the mycobacteria
themselves. Thus, Sahno et al. [26] suggested that the strains
of mycobacteria, resistant to standard chemotherapy, have
special properties with respect to induction of CD4+CD25+hi
regulatory T cells with suppressor activity [26]. Thus, we
cannot exclude the fact that in MDR TB, on the one hand,
the activation of mechanisms of immunosuppression takes
placeduetobothnaturalandadaptiveregulatoryTcells,and
on the other hand, the drug-resistant strains of the MBT may
contribute to suppression of immune response by means of
induction of Treg.
As for the role of Treg in immunopathogenesis of drug-
resistant TB, in this case it is diﬃcult to underestimate it
from the point of formation of the suppressor regime of
immunoregulation in pulmonary TB in general. From this
point of view the increase in the number of Treg at the
periphery among patients with drug-resistant TB is also
considered as a prognostically unfavourable factor leading
to prolonged course of the disease as well as immunological
discredit of the patient.
It is known that the main target cells of the inﬂuence
of Treg are the activated CD4+ and CD8+ T cells, the key
eﬀector cells of antituberculosis immunity. Naive T cells
are more sensitive to Treg than Th1 and Th2 lymphocytes
[27, 28]. The identiﬁed reduced content of T lymphocytes
with immunophenotype CD4+CD25+, which do not express
the transcription factor Foxr3, in patients with TB, regardless
of clinical forms of the disease and with no association
with drug sensitivity of the MBT to anti-tuberculosis drugs,
in comparison with the group of healthy donors (Tables 2
and 3), can probably be determined by the inhibition of
proliferation and diﬀerentiation of T helpers, as well as by
the inﬂuence of regulatory Foxp3+ T-cells with suppressor
activity and which could aﬀect the CD4+ and CD8+ T-
lymphocytes by direct contact “cell-to-cell.”
Atthesametime,thereductionofCD4+CD25+Foxp3− T
lymphocytesinperipheralbloodunderTBcanbeconsidered
as manifestation of T cell immunodeﬁciency associated with
either the initial disintegration of the immune system in8 Tuberculosis Research and Treatment
patients with TB, or with the formation of immune deﬁcien-
cy against the background of the spreading TB infection.
As mentioned above, Foxp3-negative T cells may be of
thymic origin, as well as generated at the periphery. In
addition, this subpopulation of lymphocytes is heteroge-
neous and, along with regulatory T cells, involves activated T
helpers.Thus,wecanassumethatthedecreaseinthenumber
ofTlymphocyteswiththephenotypeCD4+CD25+Foxp3− in
blood in FCTB is determined by the deﬁciency of activated T
helpers.
Itisknown,thatincaseTregcomeintoactionbycontact-
dependent way towards the CD4+-cells, the target cells
themselves gain suppressor functions: they gain the ability to
secrete cytokines inhibitors, thus, inhibiting the proliferative
and secretory activity of the secondary targets [29, 30]. In
lightoftheshownchangesandgiventhedatafromliterature,
it is obvious that the maintenance of the eﬀective immune
response in such a situation becomes impossible, which will
inevitably lead to an unfavorable clinical course of TB.
4. Summary
(1) The mechanism of immunologic deﬁciency, accom-
panying the course of pulmonary tuberculosis, is
associated with the increase of Foxp3-expressing
regulatory T cells with suppressor activity in blood,
and is associated with the reduction in the number of
CD4+CD25+Foxp3− Tl y m p h o c y t e s( Foxp3-negative
regulatory T cells and activated T helpers).
(2) Imbalance of subpopulation composition of Foxp3-
expressingregulatoryTcellsinpatientswithdiﬀerent
clinical forms of multiple drug-resistant pulmonary
tuberculosis is determined by higher content of
CD4+CD25+Foxp3+ Treg in blood in the case of DTB
and is combined with the increase in the number of
CD4+CD25−Foxp3+ adaptiveregulatoryTcellsinthe
case of ITB and FCTB.
(3) In patients with ITB, including multidrug-resistant
M. tuberculosis, an increased number of CD3+
CD4+CD25− T helpers is determined by the patho-
genic features of the development of the tuberculosis
infection and is connected with the activation of
Th1-dependent immune response. Reduction in the
number of T helpers in the blood of patients with
DTB and FCTB mediates ineﬃcient implementation
of cell-mediated protective immunity.
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